Amedisys uses data analysis to reduce HF readmissions

09/17/2013 | Advocate (Baton Rouge, La.), The

Home health and hospice care provider Amedisys uses data analysis to guide patient care and reduce hospital readmissions. CEO Bill Borne said while fluid buildup and weight gain are commonly accepted readmission warning signals in heart failure patients, its data showed a better indicator was jugular venous distension, when a patient's neck veins are swollen when they sit up.

View Full Article in:

Advocate (Baton Rouge, La.), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX